AFTATE TRIPLE ANTIBIOTIC- triple antibiotic ointment ointment

Aftate Triple Antibiotic by

Drug Labeling and Warnings

Aftate Triple Antibiotic by is a Otc medication manufactured, distributed, or labeled by Sabel Med LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DOSAGE & ADMINISTRATION

INDICATIONS & USAGE

WARNINGS

KEEP OUT OF REACH OF CHILDREN

ACTIVE INGREDIENT

INACTIVE INGREDIENT

PURPOSE

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

AFTATE TRIPLE ANTIBIOTIC 
triple antibiotic ointment ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70356-101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	5000 [iU]  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5 mg  in 1 g
BACITRACIN ZINC (UNII: 89Y4M234ES) (Bacitracin - UNII:58H6RWO52I)	Bacitracin	400 [iU]  in 1 g

Inactive Ingredients
Ingredient Name	Strength
PETROLATUM (UNII: 4T6H12BN9U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70356-101-01	28 g in 1 TUBE; Type 0: Not a Combination Product	05/01/2016
2	NDC: 70356-101-05	14 g in 1 TUBE; Type 0: Not a Combination Product	05/01/2016
3	NDC: 70356-101-33	9.4 g in 1 TUBE; Type 0: Not a Combination Product	05/01/2016

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333B	05/01/2016

Labeler - Sabel Med LLC (091476000)